Sale!

Immunohistochemistry CDK-4 Test Cost

Name: Immunohistochemistry CDK-4 Test Cost
SKU: TEST-6367
Price: 470 AED
Availability: InStock

Original price was: 530 د.إ.Current price is: 470 د.إ.

-11%

The Immunohistochemistry CDK-4 Test is a specialized diagnostic procedure employed to detect the presence and abundance of the Cyclin-Dependent Kinase 4 (CDK-4) protein in tissue samples. This test plays a crucial role in understanding various pathological conditions, particularly in the diagnosis and management of certain types of cancers. CDK-4 is a protein that is involved in cell cycle regulation, and its overexpression is often associated with the development and progression of cancer. By identifying the levels of CDK-4, healthcare providers can gain valuable insights into the aggressiveness of a tumor, predict patient outcomes, and tailor treatment strategies accordingly.

At DNA Labs UAE, the Immunohistochemistry CDK-4 Test is offered for 470 AED. The lab is equipped with state-of-the-art technology and staffed by professionals who specialize in advanced diagnostic techniques, ensuring accurate and reliable results. Patients and healthcare providers choosing DNA Labs UAE for this test can expect a high standard of service and comprehensive support throughout the testing process.

Description

IMMUNOHISTOCHEMISTRY CDK-4 Test

Test Name: IMMUNOHISTOCHEMISTRY CDK-4 Test

Components: CDK-4 protein

Price: 470.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days

Method: Immunohistochemistry

Test type: Cancer

Doctor: Oncologist, Pathologist

Test Department: Histology

Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details:

Immunohistochemistry (IHC) CDK-4 test is a diagnostic test used in pathology to detect the presence and expression levels of the Cyclin-dependent kinase 4 (CDK-4) protein in tissue samples. CDK-4 is a protein involved in cell cycle regulation and its abnormal expression has been associated with various types of cancers.

The IHC CDK-4 test involves staining tissue sections with specific antibodies against CDK-4. These antibodies bind to the CDK-4 protein if it is present in the tissue sample. The stained tissue sections are then examined under a microscope, and the presence and intensity of CDK-4 staining are evaluated.

The results of the IHC CDK-4 test can provide information about the expression levels of CDK-4 in the tissue sample, which can help in the diagnosis and prognosis of certain types of cancers. High levels of CDK-4 expression may indicate an increased risk of tumor growth and progression.

The IHC CDK-4 test is commonly used in research and clinical settings to aid in the diagnosis, prognosis, and treatment planning for various cancers, including breast cancer, melanoma, and sarcoma. It can also be used to differentiate between different subtypes of cancer and guide targeted therapy decisions.

Overall, the IHC CDK-4 test is a valuable tool in pathology for assessing CDK-4 expression in tissue samples and can provide important information for cancer diagnosis and management.

Test Name	IMMUNOHISTOCHEMISTRY CDK-4 Test
Components
Price	470.0 AED
Sample Condition	Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery	Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method	Imunohistochemistry
Test type	Cancer
Doctor	Oncologist, Pathologist
Test Department:	HISTOLOGY
Pre Test Information	Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details	Immunohistochemistry (IHC) CDK-4 test is a diagnostic test used in pathology to detect the presence and expression levels of the Cyclin-dependent kinase 4 (CDK-4) protein in tissue samples. CDK-4 is a protein involved in cell cycle regulation and its abnormal expression has been associated with various types of cancers. The IHC CDK-4 test involves staining tissue sections with specific antibodies against CDK-4. These antibodies bind to the CDK-4 protein if it is present in the tissue sample. The stained tissue sections are then examined under a microscope, and the presence and intensity of CDK-4 staining are evaluated. The results of the IHC CDK-4 test can provide information about the expression levels of CDK-4 in the tissue sample, which can help in the diagnosis and prognosis of certain types of cancers. High levels of CDK-4 expression may indicate an increased risk of tumor growth and progression. The IHC CDK-4 test is commonly used in research and clinical settings to aid in the diagnosis, prognosis, and treatment planning for various cancers, including breast cancer, melanoma, and sarcoma. It can also be used to differentiate between different subtypes of cancer and guide targeted therapy decisions. Overall, the IHC CDK-4 test is a valuable tool in pathology for assessing CDK-4 expression in tissue samples and can provide important information for cancer diagnosis and management.